Cloning and Expression of Immunogenic Regions of EMA-1 Gene of Theileria equi From Infected Horses.

The researchers have successfully used genetic engineering techniques to clone and produce a key protein – equine merozoite antigen 1 (EMA-1) – of Theileria equi, a parasite that causes equine piroplasmosis disease in horses. They showed the produced protein can be used for detection of the disease and may be used for future development of diagnostic tools and vaccines.

Study Objectives and Context

• The main purpose of this research was to clone, express, and purify the immunogenic regions of the EMA-1 gene, a key protein of Theileria equi, a parasite causing a significant disease, equine piroplasmosis, in horses.
• These cloned proteins can serve as a reliable tool for the detection of the disease in horses and potentially for the development of vaccines against this disease.

Methodology

• The researchers started by extracting the gene for the EMA-1 protein from the blood of infected horses in Iran.
• The gene was amplified and inserted into a vector (pET26b) which was then transformed into competent E. coli cells, a typical host used in gene cloning and expression.
• After growing the host cells, the researchers used isopropyl β-D-1-thiogalactopyranoside to induce the expression of the EMA-1 protein.
• The protein was then purified using nickle-nitrilotriacetic (Ni-NTA) columns, a common method for the purification of proteins.
• The cloning and expression process was verified at every step by utilizing various molecular biology techniques such as polymerase chain reaction (PCR), restriction enzyme assays, and DNA sequence analysis.

Results and Conclusions

• After the cloning, expression, and purification steps, they conducted a sequence analysis which revealed that the cloned EMA-1 protein had a high degree of similarity (94%–97%) with EMA-1 sequences from different countries in the GenBank database.
• The results of the dot blot analysis showed that the serum from infected horses containing antibodies against T. equi reacted with the purified recombinant EMA-1 protein, confirming that it can be used for the disease detection.
• The study thus successfully demonstrated that the EMA-1 protein can indeed be used as a reliable tool for the future development of diagnostic tests and possibly vaccines for equine piroplasmosis.